Description
SARS-COV2 REAGENT TESTING KITS
First action · last action
2022-01-19 · 2022-01-19
Transactions
1
First transaction's obligation
$233,280
Base + all options value (sum of deltas)
$233,280
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-01-19+$233,280= $233,280
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-01-19 | +$233,280 | $233,280 | SARS-COV2 REAGENT TESTING KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6550 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526A0045 | ABBOTT LABORATORIES INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $0 | FY2026 |
| 36C24526P0222 | CEPHEID | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $42,410 | FY2026 |
| 36C24526P0181 | FISHER SCIENTIFIC COMPANY L.L.C. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $184,136 | FY2026 |
| 36C24526N0207 | FISHER SCIENTIFIC COMPANY L.L.C. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $68,147 | FY2026 |
| 36C24526P0098 | BECTON, DICKINSON AND COMPANY | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $147,352 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24522P0210_3600_-NONE-_-NONE- · retrieved 2026-09-26.